SCHEMBL24920542

SCHEMBL24920542

COCc1ccnc(N2CCC3(CCCO3)CC2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ SLC6A2 P23975 3/20 0.38
▸ SLC6A4 P31645 3/20 0.38
▸ SLC6A3 Q01959 3/20 0.38
▸ LRRK2 Q5S007 3/20 0.38
▸ AOC3 Q16853 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ KCNH2 Q12809 1/20 0.34
▸ PIK3CA P42336 2/20 0.33
▸ MTOR P42345 2/20 0.33
▸ ACHE P22303 1/20 0.33
▸ PDCD1LG2 Q9BQ51 1/20 0.33
▸ CD274 Q9NZQ7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24920535 0.94 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3AOC3KDM4E
SCHEMBL24920536 0.81 ACHE (0.48) AOC3KDM4EMEN1ALDH1A1GAA
SCHEMBL24921023 0.80 AOC3 (0.44) AOC3KDM4EKMT2AACHE
SCHEMBL24921040 0.80 AOC3 (0.44) AOC3MEN1KMT2AACHEHTT
SCHEMBL24920520 0.79 MAPT (0.46) AOC3MEN1HPGDKMT2AACHE
SCHEMBL15740824 0.77 CYP11B1 (0.45) CYP11B1CYP11B2SLC6A2SLC6A4SLC6A3
SCHEMBL24920538 0.77 DYRK1A (0.44) LRRK2ALDH1A1L3MBTL1HTT
SCHEMBL24920548 0.75 ACHE (0.48) AOC3MEN1ALDH1A1KMT2AACHE
SCHEMBL24920567 0.75 DYRK1A (0.38) LRRK2AOC3ALDH1A1HPGDL3MBTL1
SCHEMBL24920523 0.74 ADRB1 (0.51) AOC3KDM4EALDH1A1HPGDACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 — — WO disclosed
Send feedback